10x Genomics (TXG) EBIT Growth (3y) (2021 - 2026)
Powered by 
Analysis
10x Genomics (TXG) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 9.77% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | -1.04% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 49.45% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 68.50% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 4.59% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | -7.72% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | -6.78% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -10.17% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -40.23% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 32.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.42% |
| Mar 31, 2026 | 31.04% |
| Dec 31, 2025 | 5.42% |
| Sep 30, 2025 | 6.93% |
| Jun 30, 2025 | 35.31% |
| Mar 31, 2025 | 1.96% |
| Dec 31, 2024 | -46.56% |
| Sep 30, 2024 | -37.73% |
| Jun 30, 2024 | -59.28% |
| Mar 31, 2024 | -81.91% |
| Dec 31, 2023 | 48.73% |
| Sep 30, 2023 | -13.25% |
| Jun 30, 2023 | -17.14% |
| Mar 31, 2023 | -37.76% |
| Dec 31, 2022 | -41.92% |
| Sep 30, 2022 | -63.83% |
| Jun 30, 2022 | -82.63% |
| Mar 31, 2022 | -139.58% |
| Dec 31, 2021 | 40.45% |
| Sep 30, 2021 | -2.07% |